Peters Richard — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Peters Richard has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $100K.

Profile

Peters Richard
RoleDirector
Notability10/100

Board memberships

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-06-17APREAprea Therapeutics, Inc.A — Grant or award3.1K$0.00
2025-06-30KANTKINETA, INC./DED — Derivative transaction101.9K—

Companies — Last 90 Days

Frequently Asked Questions

Who is Peters Richard?

Peters Richard is a corporate insider — currently tracked as Director of Aprea Therapeutics, Inc. (APRE). InsiderAlpha tracks every SEC Form 4 filing in real time.

How many SEC Form 4 filings has Peters Richard submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has Peters Richard been buying or selling stock?

Recorded transactions: 2 open-market purchases ($100K) and 0 open-market sales () across all tracked filings.

Where can I see all of Peters Richard's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Peters Richard profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.